New gel aims to recolor white patches on face

NCT ID NCT07357870

Recruiting now Disease control Sponsor: CAGE Bio Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests whether CGB-600 gel can safely reduce white patches from vitiligo on the face and neck. Thirty-six adults will apply the gel or a placebo twice daily for 24 weeks. Researchers will check for side effects and measure if the patches shrink by at least 50%.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CGB-600 gel
What this could lead to: If it works, this could point toward a new topical treatment to help restore skin color in people with facial vitiligo.
What could go wrong: This is a very early Phase 1 study with only 36 people, so it may not show clear benefit. The gel could cause skin irritation or other side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VITILIGO are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

vitiligo

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VITILIGO

Contacts and locations

Locations

Ankara T.C. Ministry of Health
RECRUITING

Ankara, Turkey, 06800, Turkey (Türkiye)
Istanbul Universitesi faculty of Medicine
RECRUITING

Istanbul, Turkey, 34116, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.